These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6861439)

  • 1. Theophylline kinetics in a geriatric group.
    Fox RW; Samaan S; Bukantz SC; Lockey RF
    Clin Pharmacol Ther; 1983 Jul; 34(1):60-7. PubMed ID: 6861439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking on theophylline disposition.
    Hunt SN; Jusko WJ; Yurchak AM
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):546-51. PubMed ID: 1277710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cigarette smoking and sex on theophylline disposition.
    Powell JR; Thiercelin JF; Vozeh S; Sansom L; Riegelman S
    Am Rev Respir Dis; 1977 Jul; 116(1):17-23. PubMed ID: 879596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.
    Crowley JJ; Cusack BJ; Jue SG; Koup JR; Park BK; Vestal RE
    J Pharmacol Exp Ther; 1988 May; 245(2):513-23. PubMed ID: 3367304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline kinetics in chronic obstructive airway disease in the elderly.
    Au WY; Dutt AK; DeSoyza N
    Clin Pharmacol Ther; 1985 Apr; 37(4):472-8. PubMed ID: 3919989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline kinetics in relation to age: the importance of smoking.
    Cusack B; Kelly JG; Lavan J; Noel J; O'Malley K
    Br J Clin Pharmacol; 1980 Aug; 10(2):109-14. PubMed ID: 7426272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects.
    Goto M; Nakamoto Y; Sugiyama M; Yamashina H
    J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI; French IW; Mildon CA
    Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of smoking on theophylline kinetics in healthy and asthmatic elderly males.
    Samaan S; Fox R
    J Clin Pharmacol; 1989 May; 29(5):448-50. PubMed ID: 2738176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of thyroid function on theophylline kinetics.
    Vozeh S; Otten M; Staub JJ; Follath F
    Clin Pharmacol Ther; 1984 Nov; 36(5):634-40. PubMed ID: 6488685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive steroids impair the elimination of theophylline.
    Roberts RK; Grice J; McGuffie C; Heilbronn L
    J Lab Clin Med; 1983 Jun; 101(6):821-5. PubMed ID: 6854122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.
    Bauer LA; Blouin RA
    Clin Pharmacokinet; 1981; 6(6):469-74. PubMed ID: 7318306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption properties of two theophylline sustained-release products in smokers.
    Miller R; Rheeders M
    S Afr Med J; 1984 Jun; 65(26):1045-8. PubMed ID: 6740419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
    Mellstrand T; Svedmyr K; Svedmyr N
    Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline disposition in tetraplegic man.
    Segal JL; Gordon SK; Eltorai IM
    South Med J; 1987 Jun; 80(6):720-4. PubMed ID: 3589764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.